The soluble form of CD36 (sCD36) was first described to be associated with metabolic syndrome in a small group of subjects: sCD36 was elevated in T2D patients compared with both lean (5-fold) and obese (2- to 3-fold) non-diabetic subjects [20]. The gene discussed is CD36; the disease is type 2 diabetes mellitus.